Navigation Links
Alere Inc. Statement Regarding Recommended Increased Cash Offer to Acquire Axis-Shield

WALTHAM, Mass., Oct. 6, 2011 /PRNewswire/ --

Not for release, publication or distribution, in whole or in part, in, into or from Australia, South Africa, Japan or any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction6 October 2011RECOMMENDED INCREASED CASH OFFERBYALERE AS HOLDINGS LIMITED ("ALERE AS HOLDINGS" OR THE "OFFEROR")a wholly-owned subsidiary of ALERE INC. ("ALERE")FORAXIS-SHIELD PLC ("AXIS-SHIELD" OR THE "COMPANY")The Board of Alere announces that it has reached agreement with the Board of Axis-Shield on the terms of a recommended increased cash offer for the entire issued and to be issued share capital of Axis-Shield, (the "Revised Offer").

Under the terms of the Revised Offer, Axis-Shield Shareholders will receive 470 pence in cash for each Axis-Shield Share, valuing the entire existing issued share capital of Axis-Shield at approximately 235 million pounds.

In consideration of the Revised Offer, and after consultation with the Takeover Panel, all parties have agreed to extend the timetable for the Revised Offer so that it remains open for acceptances until 24 October 2011.

Axis-Shield Shareholders who have previously accepted Alere's original offer at 460 pence for each Axis-Shield Share made on 11 August 2011 (the "Original Offer") (and have not withdrawn those acceptances) will automatically be deemed to have accepted the terms of the Revised Offer by virtue of their prior acceptances and therefore need take no further action.Other Axis-Shield Shareholders who wish to accept the Revised Offer must take action to accept the Revised Offer by 1.00 p.m. (London time) (corresponding to 2.00 p.m. Oslo time) on 24 October, 2011, which is 14 days from the date on which the document setting out, amongst other things, the detailed terms of the Revised Offer and the procedure for accepting it (the "Revised Offer Document") will be posted to Axis-Shield Shareholders.

Details of the procedure for accepting the Revised Offer will be set out in the Revised Offer Document (and, in the case of Axis-Shield UK Shareholders who hold their Axis-Shield UK Shares in certificated form, in the revised UK Form of Acceptance, and, in the case of Axis-Shield Norwegian Shareholders, in the revised Norwegian Form of Acceptance which will, in each case, accompany the Revised Offer Document) to be sent to Axis-Shield Shareholders shortly. The Revised Offer Document will also be available on Alere's website (

Axis-Shield Shareholders should carefully read the Revised Offer Document in its entirety before making a decision with respect to the Revised Offer. Unless otherwise defined herein, certain terms used in this Announcement shall have the meaning given to them in the offer document in respect of the Original Offer posted to Axis-Shield Shareholders on 11 August 2011 (the "Original Offer Document").

Enquiries:Alere Inc.Tel: +1 (781) 647 3900Jon Russell, Vice President, FinanceDoug Guarino, Spokesman, Press OfficeJefferies International Limited Tel: +44 (0)20 7029 8000(Financial Adviser & Corporate Broker)Ian Crosbie Tariq HussainJulian Smith (Corporate Broking)Citigate Dewe RogersonTel: +44 (0)20 7282 2945(Public Relations Adviser)Ginny PulbrookJos Bieneman Further InformationThe Alere Directors and Alere AS Holdings Directors accept responsibility for the information contained in this Announcement. To the best of the knowledge and belief of the Alere Directors and Alere AS Holdings Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this Announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

This Announcement does not constitute an offer to sell or an invitation to purchase or subscribe for any securities or the solicitation of an offer to buy any securities in any jurisdiction, pursuant to the Revised Offer. The Revised Offer will be made solely through the Revised Offer Document, which, in addition to the Original Offer Document, will contain the full terms and conditions of the Revised Offer, including details of how it may be accepted. Any acceptance or response to the Revised Offer should be made only on the basis of information in the Revised Offer Document.

The Revised Offer is for the securities of a corporation organised under the laws of Scotland and is subject to the procedure and disclosure requirements of the United Kingdom, which are different from those of the United States. The Revised Offer is being made in the United States pursuant to Section 14(e) of, and Regulation 14E under, the US Securities Exchange Act of 1934, as amended (the "Exchange Act"), subject to the exemptions provided by Rule 14d-1(c) under the Exchange Act and otherwise in accordance with the requirements of the Code. Accordingly, the Revised Offer is subject to disclosure and other procedural requirements, including with respect to withdrawal rights, the offer timetable, settlement procedures and timing of payments that are different from those applicable under US domestic tender offer procedures and laws.

It may be difficult for US holders of Axis-Shield Shares to enforce their rights and any claim arising out of the US federal securities laws, since Axis-Shield is located in a non-US jurisdiction, and some or all of its officers and directors may be residents of a non-US jurisdiction. US holders of Axis-Shield Shares may not be able to sue a non-US company or its officers or directors in a non-US court for violations of US securities laws. Further, it may be difficult to compel a non-US company and its affiliates to subject themselves to a US court's judgment.

The receipt of cash pursuant to the Revised Offer by a holder of Axis-Shield Shares may be a taxable transaction for US federal income tax purposes and under applicable state and local income tax laws, as well as under foreign and other tax laws. Each holder of Axis-Shield Shares is urged to consult his independent professional adviser immediately regarding the tax consequences of acceptance of the Revised Offer.

In accordance with and subject to the applicable laws and regulatory requirements of the United Kingdom and pursuant to Rule 14e-5(b) of the US Exchange Act, Alere and/or Alere AS Holdings and/or its or their nominees or brokers (acting as agents) may from time to time make purchases of, or arrangements to purchase, Axis-Shield Shares other than pursuant to the Revised Offer. These purchases, or arrangements to purchase, may occur either in the open market at prevailing prices or in private transactions at negotiated prices and shall comply with applicable rules in the United Kingdom and applicable United States securities laws. In addition, in accordance with and subject to the applicable laws and regulatory requirements of the United Kingdom and the United States, the financial advisors to Alere and Alere AS Holdings, or their respective affiliates and separately identifiable departments, may make purchases of, or arrangements to purchase, Axis-Shield Shares outside of the Revised Offer or engage in trading activities involving Axis-Shield Shares and various related derivative transactions in the normal course of their business. Any information about such purchases will be disclosed as required in the UK and will be available from the Regulatory News Service on the London Stock Exchange website, This information will also be publicly disclosed in the United States to the extent that such information is made public in the United Kingdom.

This Announcement has been prepared for the purpose of complying with English law and the Code and the information disclosed may not be the same as that which would have been disclosed if this Announcement had been prepared in accordance with the laws of other jurisdictions outside the United Kingdom. The release, publication or distribution of this Announcement in certain jurisdictions may be restricted by law. Persons who are not resident in the United Kingdom or who are subject to other jurisdictions should inform themselves of, and observe, any applicable legal or regulatory requirements. Any failure to comply with the applicable requirements may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, the companies involved in the Revised Offer disclaim any responsibility or liability for the violation of such restrictions by any person.

Neither the US Securities and Exchange Commission nor any securities commission of a state in the United States has (a) approved or disapproved of the Revised Offer; (b) passed upon the merits or fairness of the Revised Offer; or (c) passed upon the adequacy or accuracy of the disclosure in this press release. Any representation to the contrary is a criminal offence in the United States.

The availability of the Revised Offer to Axis-Shield Shareholders who are not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions in which they are resident. Persons who are not resident in the United Kingdom should inform themselves of, and observe, any applicable requirements.

Unless otherwise determined by Alere AS Holdings, this Announcement and the Revised Offer will not be made, directly or indirectly, in or into any jurisdiction where to do so would violate the laws in that jurisdiction (a "Restricted Jurisdiction") or by use of any means or instrumentality (including, without limitation, telex, facsimile transmission, telephone, internet or other forms of electronic communication) of interstate or foreign commerce, or of any facility of a national securities exchange of any Restricted Jurisdiction. Unless so determined by Alere AS Holdings, the Revised Offer will not be capable of acceptance by any such use, means or instrumentality or facility of any Restricted Jurisdiction.

Copies of this Announcement will not be, and must not be, directly or indirectly, mailed or otherwise forwarded (including, without limitation, by telex, facsimile transmission, telephone, internet or other forms of electronic communication), distributed or sent in, into or from any Restricted Jurisdiction.

Alere AS Holdings reserves the right to elect, with the consent of the Panel (where necessary), to implement the acquisition of Axis-Shield by way of a court-approved scheme of arrangement in accordance with Part 26 of the Companies Act 2006. In such event, the acquisition will be implemented on substantially the same terms, subject to appropriate amendments, as those which would apply to the Revised Offer.

Alere AS Holdings will prepare the Revised Offer Document to be distributed to Axis-Shield Shareholders in jurisdictions where it is permissible to do so. Alere AS Holdings urges Axis-Shield Shareholders to read the Revised Offer Document when it becomes available because it will contain important information relating to the Revised Offer.

Dealing Disclosure Requirements of the Code Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1 per cent. or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of: (i) the offeree company; and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

Details of the offeree and offeror companies in respect of whose relevant securities Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

Publication on WebsiteA copy of this Announcement will be made available free of charge, subject to certain restrictions relating to persons resident in Australia, South Africa, Japan or any other Restricted Jurisdictions, on Alere's website at by no later than 12.00 noon (London time) on 7 October 2011 and will remain available during the course of the Revised Offer.


SOURCE Alere Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Alere Inc. Statement Regarding Axis-Shield Offer
2. Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer
3. Alere Inc. Announces $2.1 Billion Credit Facilities
4. Alere Inc. Announces Completion of Consent Solicitations Related to its 9.0% Senior Subordinated Notes due 2016, 8.625% Senior Subordinated Notes due 2018 and 7.875% Senior Notes due 2016
5. Alere Inc. Announces Extension of Consent Solicitations Related to its 9.0% Senior Subordinated Notes Due 2016, 8.625% Senior Subordinated Notes Due 2018 and 7.875% Senior Notes Due 2016 and Increased Consent Fees
6. Alere Inc. Declares Dividend on its Series B Convertible Perpetual Preferred Stock
7. Alere to Attend the Deutsche Bank 36th Annual Health Care Conference on May 4, 2011
8. Alere Inc. Announces First Quarter 2011 Results
9. Alere Earns NCQA Health Information Products Certification for Health Information Line
10. Alere Previews Findings from Key Research Study on Medication Adherence at Integrated Benefits Institute Conference
11. Alere Inc. Announces Fourth Quarter 2010 Results
Post Your Comments:
(Date:10/8/2015)... Oct. 9, 2015 Johnson & Johnson (NYSE: ... immunogenicity clinical trial in Sierra Leone ... Janssen Pharmaceutical Companies. Trial recruitment is underway, and the first ... first study conducted of Janssen,s Ebola prime-boost vaccine regimen in ... Sierra Leone,s Kambia district, where ...
(Date:10/8/2015)...  Ardelyx, Inc. (NASDAQ: ARDX ), a ... diseases, today announced that clinical data for the ... at the 2015 American College of Gastroenterology (ACG) ... sustained response in IBS-C patients enrolled in the ... trial. The meeting will be held in ...
(Date:10/8/2015)... SAN DIEGO , Oct. 8, 2015 /PRNewswire/ ... cell-free molecular diagnostics, today announced the presentation of ... use of its Precision Cancer Monitoring SM ... can be critical for physicians to determine appropriate ... chief scientific officer of Trovagene is delivering the ...
Breaking Medicine Technology:
... February is American Heart Month and a time when ... on their family history of heart disease and recommit ... teaming up with the makers of Bayer® Aspirin and ... to raise $100,000 for the fight against heart disease. ...
... 2012 Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Leerink Swann 2012 Global Healthcare Conference to be ... New York City.  Mr. Adrian Adams, Chief Executive Officer ... the Company and its product pipeline at 10:30 a.m. ...
Cached Medicine Technology:
(Date:10/10/2015)... ... October 10, 2015 , ... Well-known Eastern ... to be recognized by The National Law Journal for inclusion in their second ... firms across the United States who obtained the largest awards for their personal ...
(Date:10/9/2015)... California (PRWEB) , ... October 09, 2015 , ... ... Osteopathic Medicine of the Pacific Associate Dean for Graduate Medical Education J. Michael ... of the Year Award. Finley was selected for his impact on graduate medical ...
(Date:10/9/2015)... ... October 09, 2015 , ... With the FCPX LUT Vibrance pack from ... A LUT is a Lookup Table that contains a mathematical formula for modifying an ... table. This pack comes with 60 vibrant CUBE LUT files. , Inspired ...
(Date:10/9/2015)... ... October 09, 2015 , ... Smoke alarms can save lives. In fact, ... risk of dying in reported home fires in half. As part of Fire Prevention ... are property installed and maintained. , Half of home fire deaths result from fires ...
(Date:10/9/2015)... ... , ... Head Over Heels Athletic Arts gymnast, Madelyn Williams, will attend the ... in Huntsville, Texas on October 17-21. , "It's very exciting to be invited ... executive director, said. “It's a stepping stone into the U.S. elite system where Maddie ...
Breaking Medicine News(10 mins):
... Neuroscientists at MIT,s Picower Institute of Learning and Memory have ... inexplicably linked to long-term memories. The work is slated to ... "Our finding explains, at least partially, why seemingly irrelevant ... person is remembered as vividly as more significant information such ...
... HealthDay Reporter , THURSDAY, Jan. 13 (HealthDay News) -- This winter ... instead is turning out to be a more typical flu season, ... to get a flu shot, advice that seniors in particular should ... their age group the hardest, the experts added. The H1N1 flu ...
... for Injury Biomechanics ( ) has been awarded ... Research and Materiel Command for phase 2 of an ... military personnel. Specifically, blast induced brain trauma will be ... helmet design and body armor and the resulting reductions ...
... Liverpool-led consortium has received $1.5million from the Bill & ... serious disease and epidemics in sub-Saharan Africa. Streptococcus ... in sub-Sahara Africa. The funding will enable scientists ... associated with invasive pneumococcal disease, why it spreads so ...
... HealthDay Reporter , THURSDAY, Jan. 13 (HealthDay ... by patients and health professionals alike to save money ... and potentially dangerous, a new study suggests. Belgian ... deviated from recommended dosages by 15 percent or more. ...
... HealthDay Reporter , WEDNESDAY, Jan. 12 (HealthDay News) -- ... said Tuesday, breathing on her own and moving both arms ... "She has a 101 percent chance of surviving," Dr. ... told the Associated Press . "She will not die." ...
Cached Medicine News:
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: